DXCM — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates DXCM as Bearish with 73% confidence in the Healthcare sector.
AI Analysis Summary
Strong bearish signal for DXCM due to extreme leverage, deteriorating technicals, and negative valuation metrics.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade B — 62/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $61.41
- Price target: $55.59 (-9.5%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: fair
- Competitive moat: none
Peer Group Analysis
DXCM is in the “Quality Cash Generators” cluster alongside YUM, WYNN, USB, VICI, V (96 stocks total). 2 of 96 peers are currently bullish.